Graphite Bio
Graphite Bio is a next-generation gene editing company focused on targeted DNA integration to precisely insert genetic payloads to treat a broad range of severe diseases.
Last updated on
About Graphite Bio
Founded
2020Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$433MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
54Location
City
South San FranciscoState
CaliforniaCountry
United StatesTech Stack (89)
